Division of Cancer Control and Population Sciences, The Colorado Trust, National Cancer Institute, Rockville, MD, USA.
Department of Epidemiology & Biostatistics, School of Medicine, University of California San Francisco, 550 16th Street, San Francisco, CA, USA.
J Cancer Surviv. 2019 Dec;13(6):968-980. doi: 10.1007/s11764-019-00820-7. Epub 2019 Oct 23.
To examine whether interpersonal aspects of patient-clinician interactions, such as patient-perceived medical discrimination, clinician mistrust, and treatment decision-making contribute to racial/ethnic/educational disparities in breast cancer care.
A telephone interview was administered to 542 Asian/Pacific Islander (API), Black, Hispanic, and White women identified through the Greater Bay Area Cancer Registry, ages 20 and older diagnosed with a first primary invasive breast cancer. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were calculated from logistic regression models that assessed associations between race/ethnicity/education, medical discrimination, clinician mistrust, and treatment decision-making with concordance to breast cancer treatment guidelines (guideline-concordant treatment) and perceived quality of care (pQoC).
Approximately three-quarters of women received treatment that was guideline-concordant (76.6%) and reported that their breast cancer care was excellent (72.1%). Non-college-educated Black women had lower odds of guideline-concordant care (aOR (CI) = 0.29 (0.12-0.67)) vs. college-educated White women. Odds of excellent pQoC were lower among the following: college-educated Hispanic women (aOR (CI) = 0.09 (0.02-0.47)) and API women regardless of education (aORs ≤ 0.50) vs. college-educated White women, women reporting low and moderate levels of discrimination (aORs ≤ 0.44) vs. none, and women reporting any clinician mistrust (aOR (CI) = 0.50 (0.29-0.88)) vs. none. Disparities in guideline-concordant care and pQoC persisted after controlling for medical discrimination, clinician mistrust, and decision-making.
Interpersonal aspects of the patient-clinician interaction had an impact on pQoC but not receipt of guideline-concordant treatment and did not explain disparities in either outcome.
Although breast cancer survivors' interpersonal interactions with clinicians did not influence receipt of appropriate treatment, intervention strategies to improve patient-clinician relations may help attenuate disparities in survivors' pQoC.
探讨医患互动中的人际方面,如患者感知的医疗歧视、医生不信任以及治疗决策是否会导致乳腺癌护理中的种族/民族/教育差异。
通过加利福尼亚海湾地区癌症登记处,对 542 名年龄在 20 岁及以上、被诊断为首次原发性浸润性乳腺癌的亚裔/太平洋岛民(API)、黑种人、西班牙裔和白种妇女进行了电话采访。使用逻辑回归模型评估了种族/民族/教育、医疗歧视、医生不信任和治疗决策与乳腺癌治疗指南(指南一致的治疗)和感知护理质量(pQoC)之间的关联,计算了调整后的优势比(aOR)和 95%置信区间(CI)。
大约四分之三的妇女接受了符合指南的治疗(76.6%),并报告她们的乳腺癌护理非常出色(72.1%)。与受过大学教育的白人妇女相比,未受过大学教育的黑人妇女接受符合指南的治疗的可能性较低(aOR(CI)=0.29(0.12-0.67))。以下人群的优秀 pQoC 几率较低:受过大学教育的西班牙裔妇女(aOR(CI)=0.09(0.02-0.47))和无论教育程度如何的 API 妇女(aORs≤0.50)与受过大学教育的白人妇女相比,报告低和中度歧视的妇女(aORs≤0.44)与无报告者相比,以及报告任何医生不信任的妇女(aOR(CI)=0.50(0.29-0.88))与无报告者相比。在控制了医疗歧视、医生不信任和决策后,符合指南的治疗和 pQoC 的差异仍然存在。
医患互动中的人际方面对 pQoC 有影响,但对接受符合指南的治疗没有影响,也不能解释这两种结果的差异。
尽管乳腺癌幸存者与医生的人际互动并未影响接受适当的治疗,但干预策略改善医患关系可能有助于减轻幸存者 pQoC 的差异。